Abstract
While the pathogenic role of dicarbonyl stress and accelerated formation of advanced glycation end products (AGEs) to glucose intolerance and to the development of diabetic complications is well established, little is known about these processes in gestational diabetes mellitus (GDM), a condition pathogenically quite similar to type 2 diabetes. The aims of the present study were (i) to determine plasma thiamine and erythrocyte thiamine diphosphate (TDP) and transketolase (TKT) activity in pregnant women with and without GDM, (ii) to assess relationships between thiamine metabolism parameters and selected clinical, biochemical and anthropometric characteristics and, finally, (iii) to analyse relationship between variability in the genes involved in the regulation of transmembrane thiamine transport (i.e. SLC19A2 and SLC19A3) and relevant parameters of thiamine metabolism. We found significantly lower plasma BMI adjusted thiamine in women with GDM (P = 0.002, Mann-Whitney) while levels of erythrocyte TDP (an active TKT cofactor) in mid-trimester were significantly higher in GDM compared to controls (P = 0.04, Mann-Whitney). However, mid-gestational TKT activity - reflecting pentose phosphate pathway activity - did not differ between the two groups (P > 0.05, Mann-Whitney). Furthermore, we ascertained significant associations of postpartum TKT activity with SNPs SLC19A2 rs6656822 and SLC19A3 rs7567984 (P = 0.03 and P = 0.007, resp., Kruskal-Wallis). Our findings of increased thiamine delivery to the cells without concomitant increase of TKT activity in women with GDM therefore indicate possible pathogenic role of thiamine mishandling in GDM. Further studies are needed to determine its contribution to maternal and/or neonatal morbidity.
Similar content being viewed by others
Abbreviations
- AGEs:
-
advanced glycation end products
- BMI:
-
body mass index
- FPG:
-
fasting plasma glucose
- GDM:
-
gestational diabetes mellitus
- HPLC:
-
high-performance liquid chromatography
- oGTT:
-
oral glucose tolerance test
- PPP:
-
pentose phosphate pathway
- SLC19A2:
-
solute carrier family 19 member 2
- SLC19A3:
-
solute carrier family 19 member 3
- SNP:
-
single nucleotide polymorphism
- TDP:
-
thiamine diphosphate
- THTR1:
-
thiamine transporter 1
- THTR2:
-
thiamine transporter 2
- TKT:
-
transketolase
- TPK1:
-
thiamine pyrophosphokinase
- T2DM:
-
type 2 diabetes mellitus
References
Huebschmann A.G., Regensteiner J.G., Vlassara H., Reusch J.E.: Diabetes and advanced glycoxidation end products. Diabetes Care. 29(6), 1420–1432 (2006)
Ramasamy R., Yan S.F., Schmidt A.M.: Advanced glycation endproducts: from precursors to RAGE: round and round we go. Amino Acids. 42(4), 1151–1161 (2012)
Coughlan M.T., Yap F.Y., Tong D.C., Andrikopoulos S., Gasser A., Thallas-Bonke V., Webster D.E., Miyazaki J., Kay T.W., Slattery R.M., Kaye D.M., Drew B.G., Kingwell B.A., Fourlanos S., Groop P.H., Harrison L.C., Knip M., Forbes J.M.: Advanced glycation end products are direct modulators of β-cell function. Diabetes. 60(10), 2523–2532 (2011)
Engelen L., Stehouwer C.D., Schalkwijk C.G.: Current therapeutic interventions in the glycation pathway: evidence from clinical studies. Diabetes Obes Metab. 15(8), 677–689 (2013)
Uribarri J., Cai W., Ramdas M., Goodman S., Pyzik R., Chen X., Zhu L., Striker G.E., Vlassara H.: Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1. Diabetes Care. 34(7), 1610–1616 (2011)
Harlev A., Wiznitzer A.: New insights on glucose pathophysiology in gestational diabetes and insulin resistance. Curr Diab Rep. 10(3), 242–247 (2010)
Reece E.A., Leguizamón G., Wiznitzer A.: Gestational diabetes: the need for a common ground. Lancet. 373(9677), 1789–1797 (2009)
Bellamy L., Casas J.P., Hingorani A.D., Williams D.: Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 373(9677), 1773–1779 (2009)
Harsem N.K., Braekke K., Torjussen T., Hanssen K., Staff A.C.: Advanced glycation end products in pregnancies complicated with diabetes mellitus or preeclampsia. Hypertens Pregnancy. 27(4), 374–386 (2008)
Guosheng L., Hongmei S., Chuan N., Haiying L., Xiaopeng Z., Xianqiong L.: The relationship of serum AGE levels in diabetic mothers with adverse fetal outcome. J. Perinatol. 29(7), 483–488 (2009)
Buongiorno A.M., Morelli S., Sagratella E., Castaldo P., Di Virgilio A., Maroccia E., Ricciardi G., Sciullo E., Cardellini G., Fallucca F., Sensi M.: Levels of advanced glycosylation end-products (AGE) in sera of pregnant diabetic women: comparison between type 1, type 2 and gestational diabetes mellitus. Ann. Ist. Super. Sanita. 33(3), 375–378 (1997)
Bartakova, V., Kollarova, R., Kuricova, K., Sebekova, K., Belobradkova, J., Kankova, K.: Serum carboxymethyl-lysine, a dominant advanced glycation end product, is increased in women with gestational diabetes mellitus. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. (2015).
Talwar D., Davidson H., Cooney J., St J.R.D.: Vitamin B(1) status assessed by direct measurement of thiamin pyrophosphate in erythrocytes or whole blood by HPLC: comparison with erythrocyte transketolase activation assay. Clin. Chem. 46(5), 704–710 (2000)
Lynch P.L., Young I.S.: Determination of thiamine by high-performance liquid chromatography. J Chromatogr A. 881(1–2), 267–284 (2000)
Rabbani N., Thornalley P.J.: Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy. Diabetes Obes Metab. 13(7), 577–583 (2011)
Thornalley P.J., Babaei-Jadidi R., Al Ali H., Rabbani N., Antonysunil A., Larkin J., Ahmed A., Rayman G., Bodmer C.W.: High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia. 50(10), 2164–2170 (2007)
Babaei-Jadidi R., Karachalias N., Ahmed N., Battah S., Thornalley P.J.: Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes. 52(8), 2110–2120 (2003)
Pacal L., Kuricova K., Kankova K.: Evidence for altered thiamine metabolism in diabetes: is there a potential to oppose gluco- and lipotoxicity by rational supplementation? World J Diabetes. 5(3), 288–295 (2014)
Labay V., Raz T., Baron D., Mandel H., Williams H., Barrett T., Szargel R., McDonald L., Shalata A., Nosaka K., Gregory S., Cohen N.: Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat. Genet. 22(3), 300–304 (1999)
Zeng W.Q., Al-Yamani E., Acierno Jr. J.S., Slaugenhaupt S., Gillis T., MacDonald M.E., Ozand P.T., Gusella J.F.: Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. Am. J. Hum. Genet. 77(1), 16–26 (2005)
Fradin D., Bougneres P.: Three common intronic variants in the maternal and fetal thiamine pyrophosphokinase gene (TPK1) are associated with birth weight. Ann. Hum. Genet. 71(Pt 5), 578–585 (2007)
Butterworth R.F.: Maternal thiamine deficiency. A factor in intrauterine growth retardation. Ann N Y Acad Sci. 678, 325–329 (1993)
Baker H., Frank O., Thomson A.D., Langer A., Munves E.D., De Angelis B., Kaminetzky H.A.: Vitamin profile of 174 mothers and newborns at parturition. Am. J. Clin. Nutr. 28(1), 59–65 (1975)
Losa R., Sierra M.I., Fernández A., Blanco D., Buesa J.M.: Determination of thiamine and its phosphorylated forms in human plasma, erythrocytes and urine by HPLC and fluorescence detection: a preliminary study on cancer patients. J. Pharm. Biomed. Anal. 37(5), 1025–1029 (2005)
Brunnekreeft J.W., Eidhof H., Gerrits J.: Optimized determination of thiochrome derivatives of thiamine and thiamine phosphates in whole blood by reversed-phase liquid chromatography with precolumn derivatization. J. Chromatogr. 491(1), 89–96 (1989)
Pacal L., Tomandl J., Svojanovsky J., Krusova D., Stepankova S., Rehorova J., Olsovsky J., Belobradkova J., Tanhauserova V., Tomandlova M., Muzik J., Kankova K.: Role of thiamine status and genetic variability in transketolase and other pentose phosphate cycle enzymes in the progression of diabetic nephropathy. Nephrol. Dial. Transplant. 26(4), 1229–1236 (2011)
Heller S., Salkeld R.M., Korner W.F.: Vitamin B1 status in pregnancy. Am. J. Clin. Nutr. 27(11), 1221–1224 (1974)
Baker H., DeAngelis B., Holland B., Gittens-Williams L., Barrett Jr. T.: Vitamin profile of 563 gravidas during trimesters of pregnancy. J. Am. Coll. Nutr. 21(1), 33–37 (2002)
Ho J.E., Larson M.G., Vasan R.S., Ghorbani A., Cheng S., Rhee E.P., Florez J.C., Clish C.B., Gerszten R.E., Wang T.J.: Metabolite profiles during oral glucose challenge. Diabetes. 62(8), 2689–2698 (2013)
Acknowledgments
Study was supported by the grant NT13198 from The Ministry of Health of Czech Republic.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Bartáková, V., Pleskačová, A., Kuricová, K. et al. Dysfunctional protection against advanced glycation due to thiamine metabolism abnormalities in gestational diabetes. Glycoconj J 33, 591–598 (2016). https://doi.org/10.1007/s10719-016-9688-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-016-9688-9